Alexis Borisy Blueprint Medicines Corp (BPMC) insider trading activity

Alexis Borisy is of Blueprint Medicines Corp. Currently has a direct ownership of 78,062 shares of BPMC, which is worth approximately $10 Million. The most recent transaction as insider was on Jun 18, 2025, when has been sold 3,902 shares (Common Stock) at a price of $128.12 per share, resulting in proceeds of $499,924. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.1K

5.26% 3M change

5.26% 12M change

Total Value Held $10 Million

Alexis Borisy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2025	BUY Grant, award, or other acquisition	$499,924 $128.12 p/Share	3,902 Added 4.76%	78,062 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	2,242 Added 2.93%	74,160 Common Stock
Jun 21 2023	BUY Grant, award, or other acquisition	-	2,600 Added 3.49%	71,918 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	-	2,600 Added 3.62%	69,318 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,250 Added 3.26%	66,718 Common Stock

Also insider at

RLAY

Relay Therapeutics, Inc. Healthcare

MGTA

Magenta Therapeutics, Inc. Healthcare

Director

RVMD

Revolution Medicines, Inc. Healthcare

EQRX

EQRx, Inc. Healthcare

Executive Chairman

OPK

OPKO HEALTH, INC. Healthcare

Director

TNGX

Tango Therapeutics, Inc. Healthcare

Alexis Borisy

Miami, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Value

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC

Account